Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Concin

Showing results (31-40 of 132) with videos related to

Pageof 14
Sort By:
Gynecologic Oncology|March 6, 2024
2023 FIGO staging system for endometrial cancer: The evolution of the revolutionDavid Gaffney, Xavier Matias-Guiu, David Mutch, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Does duration of hysteroscopy increase the risk of disease recurrence in patients with endometrial cancer? A multi-centre trialClemens Tempfer, Georg Froese, Bernd Buerkle, et al.
Anticancer Research|March 25, 2010
Repeat surgery in patients with cervical cancer stage FIGO IA1: a series of 156 cases and a review of the literatureLukas A Hefler, Stephan Polterauer, Alois Schneitter, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 6, 2023
Response: FIGO staging of endometrial cancer 2023Nicole Concin, Xavier Matias-Guiu, Christina Fotopoulou, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 20, 2023
FIGO staging of endometrial cancer: 2023Jonathan S Berek, Xavier Matias-Guiu, Carien Creutzberg, et al.
Anticancer Research|July 15, 2009
Pros and cons of intraperitoneal chemotherapy in the treatment of epithelial ovarian cancerAlain G Zeimet, Daniel Reimer, Alice C Radl, et al.
Gynecologic Oncology|April 16, 2003
Biological markers in pT1 and pT2 ovarian cancer with lymph node metastasesNicole Concin, Lukas Hefler, Jeroen van Bavel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patientsDaniel Reimer, Susann Sadr, Annemarie Wiedemair, et al.
Gynecologic Oncology|February 27, 2004
A polymorphism of the interleukin-1 receptor antagonist plays a prominent role within the interleukin-1 gene cluster in vulvar carcinogenesisChristoph Grimm, Ingrid Berger, Caroline Tomovski, et al.
Analytical Chemistry|October 3, 2018
Polymer-Ligand-Based ELISA for Robust, High-Throughput, Quantitative Detection of p53 AggregatesElisabeth Maritschnegg, Nicole Heinzl, Stuart Wilson, et al.
Pageof 14

Showing results (31-40 of 132) with videos related to

Sort By:
Pageof 14
Gynecologic Oncology|March 6, 2024
2023 FIGO staging system for endometrial cancer: The evolution of the revolutionDavid Gaffney, Xavier Matias-Guiu, David Mutch, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Does duration of hysteroscopy increase the risk of disease recurrence in patients with endometrial cancer? A multi-centre trialClemens Tempfer, Georg Froese, Bernd Buerkle, et al.
Anticancer Research|March 25, 2010
Repeat surgery in patients with cervical cancer stage FIGO IA1: a series of 156 cases and a review of the literatureLukas A Hefler, Stephan Polterauer, Alois Schneitter, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 6, 2023
Response: FIGO staging of endometrial cancer 2023Nicole Concin, Xavier Matias-Guiu, Christina Fotopoulou, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 20, 2023
FIGO staging of endometrial cancer: 2023Jonathan S Berek, Xavier Matias-Guiu, Carien Creutzberg, et al.
Anticancer Research|July 15, 2009
Pros and cons of intraperitoneal chemotherapy in the treatment of epithelial ovarian cancerAlain G Zeimet, Daniel Reimer, Alice C Radl, et al.
Gynecologic Oncology|April 16, 2003
Biological markers in pT1 and pT2 ovarian cancer with lymph node metastasesNicole Concin, Lukas Hefler, Jeroen van Bavel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patientsDaniel Reimer, Susann Sadr, Annemarie Wiedemair, et al.
Gynecologic Oncology|February 27, 2004
A polymorphism of the interleukin-1 receptor antagonist plays a prominent role within the interleukin-1 gene cluster in vulvar carcinogenesisChristoph Grimm, Ingrid Berger, Caroline Tomovski, et al.
Analytical Chemistry|October 3, 2018
Polymer-Ligand-Based ELISA for Robust, High-Throughput, Quantitative Detection of p53 AggregatesElisabeth Maritschnegg, Nicole Heinzl, Stuart Wilson, et al.
Pageof 14